These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3987619)

  • 21. Interaction of DP-TAT-59, an active metabolite of new triphenylethylene-derivative (TAT-59), with estrogen receptors.
    Toko T; Matsuo K; Shibata J; Wierzba K; Nukatsuka M; Takeda S; Yamada Y; Asao T; Hirose T; Sato B
    J Steroid Biochem Mol Biol; 1992 Nov; 43(6):507-14. PubMed ID: 1419885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogenic and progestational activity of 7alpha-methyl-19-nortestosterone, a synthetic androgen.
    Beri R; Kumar N; Savage T; Benalcazar L; Sundaram K
    J Steroid Biochem Mol Biol; 1998 Nov; 67(3):275-83. PubMed ID: 9879986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue.
    Gibson MK; Nemmers LA; Beckman WC; Davis VL; Curtis SW; Korach KS
    Endocrinology; 1991 Oct; 129(4):2000-10. PubMed ID: 1915080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships.
    Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential stimulation by 17 beta-estradiol and synthetic estrogens of progesterone-receptor and of translocation of estrogen-receptor in rat pituitary and uterus.
    Leibl H; Spona J
    Endocrinology; 1982 Jan; 110(1):265-71. PubMed ID: 7053987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporally distinct and ligand-specific recruitment of nuclear receptor-interacting peptides and cofactors to subnuclear domains containing the estrogen receptor.
    Schaufele F; Chang CY; Liu W; Baxter JD; Nordeen SK; Wan Y; Day RN; McDonnell DP
    Mol Endocrinol; 2000 Dec; 14(12):2024-39. PubMed ID: 11117532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tamoxifen decreases the estradiol induced progesterone receptors by interfering with nuclear estrogen receptor accumulation.
    Castellano-Díaz E; González-Quijano MI; Limiñana JM; Díaz-Chico BN
    J Steroid Biochem; 1989 Jul; 33(1):133-9. PubMed ID: 2761261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological responses of tamoxifen in the fetal and newborn vagina and uterus of the guinea-pig and in the R-27 mammary cancer cell line.
    Pasqualini JR; Giambiagi N; Sumida C; Nguyen BL; Gelly C; Mayrand C; Lecerf F
    J Steroid Biochem; 1986 Jan; 24(1):99-108. PubMed ID: 3702432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Geometric isomers of substituted triphenylethylenes and antiestrogen action.
    Jordan VC; Haldemann B; Allen KE
    Endocrinology; 1981 Apr; 108(4):1353-61. PubMed ID: 6781873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity.
    Ruh MF; Zacharewski T; Connor K; Howell J; Chen I; Safe S
    Biochem Pharmacol; 1995 Oct; 50(9):1485-93. PubMed ID: 7503800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationships among sex steroids, oxytocin, and their receptors in the rat uterus during late gestation and at parturition.
    Fang X; Wong S; Mitchell BF
    Endocrinology; 1996 Aug; 137(8):3213-9. PubMed ID: 8754742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V; Gougelet A; Maillard S; Renoir JM
    Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormonal effects on unoccupied estrogen receptors in nuclei of anterior pituitary glands.
    Weisenberg LS; Ortí E; Piroli G; Libertun C; De Nicola AF
    Acta Physiol Pharmacol Latinoam; 1986; 36(4):473-87. PubMed ID: 3604707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uterine estrogen receptor interaction with estrogen-responsive DNA sequences in vitro: effects of ligand binding on receptor-DNA complexes.
    Curtis SW; Korach KS
    Mol Endocrinol; 1990 Feb; 4(2):276-86. PubMed ID: 2330006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo binding of toremifene and its metabolites in rat uterus.
    Simberg NH; Murai JT; Siiteri PK
    J Steroid Biochem; 1990 Jun; 36(3):197-202. PubMed ID: 2142232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A naturally occurring estrogen receptor mutation results in increased estrogenicity of a tamoxifen analog.
    Catherino WH; Wolf DM; Jordan VC
    Mol Endocrinol; 1995 Aug; 9(8):1053-63. PubMed ID: 7476979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen.
    Lim YC; Desta Z; Flockhart DA; Skaar TC
    Cancer Chemother Pharmacol; 2005 May; 55(5):471-8. PubMed ID: 15685451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of nafoxidine on the luteinizing hormone surge: temporal distribution of estrogen receptors and induction of cytoplasmic progestin receptors in the hypothalamus-preoptic area, pituitary, and uterus of the immature rat.
    Attardi B; Palumbo LA
    Endocrinology; 1981 Nov; 109(5):1365-74. PubMed ID: 7297482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opposing biological actions of antiestrogens in vitro and in vivo: induction of progesterone receptor in the rat and mouse uterus.
    Campen CA; Jordan VC; Gorski J
    Endocrinology; 1985 Jun; 116(6):2327-36. PubMed ID: 3996316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of antibodies to estrogen receptor on the binding of 3H-labeled antiestrogens and androstanediol in the uterus.
    Garcia M; Greene G; Rochefort H; Jensen EV
    Endocrinology; 1982 Apr; 110(4):1355-61. PubMed ID: 7060530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.